40.8% of denied claims are resubmitted and paid with no appeal involved -- a peer-reviewed number, from Medicare Advantage, with no behavioral-health breakout anywhere
The question
"What share of initially denied behavioral-health claims are resubmitted and paid WITHOUT a formal appeal -- i.e. how big is the quiet rework market, as distinct from the near-zero appeals market?"
This is open follow-up #4 of [[2026-10-04-behavioral-health-claim-denial-rate-primary-sources]], which established the appeals market as effectively nonexistent and then declined to estimate the rework market. This pass finds the quantity exists and is published, but only on an all-specialty Medicare Advantage base.
What we already know (from the vault)
- The appeals market is a rounding error, from two independent primary sources. Virginia's Bureau of Insurance closed 9,429 internal appeals against roughly 16.2 million denied claims in calendar year 2023 (0.06%), with only 124 internal appeals across all substance-use-disorder denials. KFF's analysis of CMS transparency data reports fewer than 1% of roughly 85 million denied HealthCare.gov in-network claims were appealed in plan year 2024. Both from [[2026-10-04-behavioral-health-claim-denial-rate-primary-sources]].
- The parent brief named this gap and refused to fill it. Its words: "Rework and resubmission, which neither dataset measures, is where the labor actually goes. That is a gap worth naming rather than filling with an estimate." It was right that Virginia and CMS do not measure it. It was wrong that nobody does.
- The parent brief's relocation finding is the thing this pass has to confirm or break. Medical necessity accounts for 1.4% of categorized Virginia substance-use-disorder denials; provider and administrative billing accounts for 20.3%; preauthorization and precertification accounts for 32.9% of non-pharmacy substance-use-disorder denials against 5.0% for medical/surgical. Its conclusion: "An EOB-parsing and denial-appeal layer is aimed downstream of where the money leaks; the leak is upstream, at authorization capture and first-pass claim construction."
- Mental health is not the elevated block; substance use disorder is. On non-pharmacy claims Virginia puts mental health at 1.13x medical/surgical and substance use disorder at 2.73x ([[2026-10-04-behavioral-health-claim-denial-rate-primary-sources]], author arithmetic on published rows).
- The convergence to test. [[2026-09-17-cfo-secrets-double-entry-bookkeeping-ramp]] argues accounting friction comes from a "Cone of Accounting Bullshit" in which one economic event is estimated, accrued, reversed, coded, reclassified and remapped "because the accounting/timing/metadata weren't captured at the moment the transaction happened," and that finance should be "relentless about shrinking the gap between the business event and the accounting transaction." That doc is a Ramp advertorial and flagged
sponsored: true; its diagnosis travels, its vendor conclusion does not.
What the web says
The volume question (share of denials resubmitted and paid). This is a percentage, not a dollar figure.
- 40.8% of all initial denials are resubmitted and overturned. First-party, peer-reviewed, full text read at source. Vabson B, Hicks AL, Chernew ME, "Medicare Advantage Denies 17 Percent Of Initial Claims; Most Denials Are Reversed, But Provider Payouts Dip 7 Percent," Health Affairs 44(6), published 2 June 2025. Verbatim from the Study Results section: "We found that 60 percent of all denied claims were resubmitted, with two-thirds of resubmitted denials being overturned (or 40.8 percent as a fraction of all initial denials, including non-resubmitted)." Base: 270 million Medicare Advantage medical claim submissions from calendar year 2019, Inovalon data covering about 30% of Medicare Advantage enrollment, across inpatient, outpatient, professional and postacute care. Initial denial rate 17.7% of submissions. All-specialty, not behavioral-health-specific.
- The study never mentions appeals in its body, which is what makes the number answer this question. A full-text scan returns "appeal" only inside reference 14, a citation to a KFF marketplace brief. The measured event is a second claim submission in claims data, which is structurally not a formal appeal. So 40.8% is the resubmit-and-paid share, cleanly separated from the appeals channel, and it is measured rather than inferred.
- The rework loop is one shot, not a tail. Verbatim: "Fewer than 1 percent of claims will get resubmitted conditional on a second denial." Whatever value exists has to be created before the first submission or at the first correction. There is no second bite.
- A denominator trap sits inside the same paper, and it is the kind that produces wrong headlines. The abstract says "57 percent of all claim denials were ultimately overturned" and the results say "Overturned denials constituted 56.6 percent of original denials, as a dollar share of billings." The 40.8% is a claim-count share and the 56.6% is a dollar share. They are not the same statistic, and most secondary write-ups carry only the 57%. Becker's Payer Issues (10 June 2025) reports the 17% and 57% and does not mention resubmission at all, so anyone working from secondary coverage never sees the number this question asks for.
- The study's own limitations cut directly at the upstream argument. Verbatim: "We also did not have the ability to distinguish between different types of denials — in particular, between administrative denials tied to clerical errors versus clinical denials tied to the underlying medical value of services rendered." It also covers only full denials, not partial denials or claim-line adjustments, and uses a nonrandom carrier sample "skewed toward regional plans." So it sizes the rework market without telling us how much of it is clerical.
- Behavioral health appears nowhere in it. A full-text scan for "behavioral," "mental health," "psych" and "substance" returns zero hits in all four cases. The single best measurement of the quiet rework market has no behavioral-health cut.
- First-party avoidability data exists and is the strongest upstream evidence found. The Change Healthcare 2022 Revenue Cycle Denials Index (downloaded and read as the original PDF; internal analysis of roughly 441 million hospital claim remits valued at $500 billion in total charges across more than 1,500 US hospitals, processed July 2021 through June 2022): about 82% of denials are potentially avoidable, split 31% unequivocally avoidable and 51% situationally avoidable, with 18% unavoidable. Of the avoidable group, 43% cannot be recovered. Front-end denials account for more than 41% of denials in the first half of 2022. Registration and eligibility is the top root cause at 22% and, per the report's own slide heading, is "frequently non-recoverable." Authorization and pre-certification follows at 13%. Hospital inpatient and outpatient only, all-specialty, no behavioral-health cut, and vendor-published internal analysis rather than survey.
The cost question (dollars per reworked claim). This is a dollar figure, not a share, and none of it can be converted into the volume question.
- $25.20 to rework one denied claim -- MGMA, published March 2021, no sample, no denominator, no data year, all-specialty. This is the single most-circulated rework number in the industry and its provenance is thin. The attribution chain runs through an MGMA Stat item ("6 keys to addressing denials in your medical practice's revenue cycle"); MGMA attaches no population, sample size or activity year to it. Treat it as a widely-repeated benchmark, not a measured figure.
- $118 per denied claim is a FORMAL APPEAL figure, not a rework figure, and it cannot be traced to a current first-party publication. It is attributed to an MGMA article of December 2018 citing a Change Healthcare index dated to 2017 (the Healthy Hospital Revenue Cycle Index), hospital setting. I downloaded the 2022 Change Healthcare Revenue Cycle Denials Index, which is the successor publication and the one the Health Affairs authors cite as their reference 12, and searched it: it contains no cost-per-claim figure of any kind, no rework cost, no appeal cost, and no resubmission share. So the $118 traces at best to a superseded 2017 index that the current first-party document does not reproduce.
- Therefore the "$25 to $118" range that circulates as a single benchmark is a splice. It joins two different units of work (practice-level rework versus hospital formal appeal), two different settings, and two different years, and neither endpoint carries a published sample. Several vendor pages attribute the range to MGMA, several to HFMA, and one to "MGMA and HFMA research." No first-party publication of the range was located. Saying this is the finding; citing the range as one number is the error.
- Premier's figures are a third unit again. $43.84 for 2022 activity (published March 2024) and $57.23 for 2023 activity (published February 2025), described as the cost of full adjudication of a disputed claim for hospitals and health systems. First-party Premier, all-specialty.
- Paywalled and not retried, per instruction: MGMA and HFMA member-only benchmarking libraries, where any properly sampled rework-cost-per-claim survey would live. Academic revenue-cycle literature beyond the open Health Affairs text was not pursued.
- No cost-per-reworked-claim figure specific to behavioral health, applied behavior analysis, or substance use disorder was found in any source of any class.
Convergences and contradictions
- Convergence, and it is the headline. The vault had the appeals denominator and no rework numerator; Health Affairs supplies the numerator. Put side by side on Virginia's own substance-use-disorder rows: 133,009 substance-use-disorder denials in calendar year 2023, against 124 internal appeals. Apply the 40.8% resubmit-and-paid share and roughly 54,300 of those denials were corrected, resubmitted and paid, against 124 appealed. That is a ratio near 440 to 1, inside one service line, one state and one market segment. Expressed as rates rather than counts, the rework channel runs 41x the appeals channel on KFF's sub-1% ACA figure and about 680x on Virginia's 0.06%. Every one of those ratios splices a Medicare Advantage numerator onto a commercial denominator and is a shape, not a measurement.
- Contradiction with the parent brief's framing, not its conclusion. The parent brief said the rework share was unmeasured and should not be estimated. It is measured, well, on 270 million claims, by three health-economics authors, in a journal, with the full text openly readable. The lesson for
/deep-researchis that the parent brief searched for behavioral-health denial data and therefore never hit the Medicare Advantage literature where the rework statistic actually lives. Narrow vertical framing hid a general-population answer. - Contradiction inside the upstream story. Health Affairs says the modal denial gets fixed and paid, which makes rework look like the recurring labor to automate. Change Healthcare says the largest single avoidable category, registration and eligibility at 22% of root causes, is "frequently non-recoverable," and that 43% of unequivocally avoidable denials cannot be recovered at all. Both can be true: most denials are recoverable by rework, and the biggest preventable bucket is the one rework cannot touch. Those two facts point at different products.
Synthesis for RDCO
The answer to the question as asked is a split verdict: the quantity is published and large, and the behavioral-health version of it is a clean null. 40.8% of initially denied claims are resubmitted and paid with no appeal, measured on 270 million Medicare Advantage claims from 2019 by Vabson, Hicks and Chernew. Nobody publishes that share for behavioral health, applied behavior analysis or substance use disorder. Health Affairs has zero behavioral-health mentions; KFF cannot link denial reasons to services ("neither the share of total claims denied for a given reason nor the type of service most often denied can be calculated"); Virginia does not define whether its "denied" counts initial determinations or final status after resubmission, and does not report resubmission at all. The measurement is coming on a known date: KFF reports CMS will add a behavioral-health versus non-behavioral-health split of claims received and denied for plan year 2027. Until then, any behavioral-health rework share is a borrowed number.
Best defensible bound, with the arithmetic shown and every assumption labelled. Assumption 1: the behavioral-health resubmit-and-paid share approximates the all-specialty Medicare Advantage share of 40.8%. Direction of error is arguable in both directions and I will not pretend otherwise. Pushing it higher: Virginia attributes 20.3% of substance-use-disorder denials to provider and administrative billing and 32.9% of non-pharmacy substance-use-disorder denials to preauthorization or precertification, against only 1.4% to medical necessity, and correctable-cause denials are exactly the ones a resubmission fixes. Pushing it lower: a missing prior authorization is often unobtainable retroactively, and behavioral-health practices are smaller with thinner billing capacity than the hospital and Medicare Advantage mix behind the 40.8%. Treat 40.8% as a midpoint, not a floor. Assumption 2: Virginia's 133,009 substance-use-disorder and 2,006,618 mental-health denials are initial denials. If they are instead final post-resubmission denials, applying 40.8% double counts and the whole estimate collapses. This is the largest single threat to the arithmetic and the parent brief already flagged the ambiguity. On those two assumptions: roughly 873,000 behavioral-health denials per year are reworked and paid inside Virginia's state-regulated fully-insured commercial market alone, covering 2.48 million lives, of which roughly 54,300 are substance use disorder. Do not scale that to the nation off a population ratio. Virginia's segment excludes Medicaid managed care, which is where the larger substance-use-disorder book sits, so the figure is a floor measured on the wrong denominator rather than a unit that multiplies.
Separately, and never multiplied into the above as if it were the same quantity: the labor price of one rework event is roughly $25 and has no published sample behind it. The one arithmetic worth doing is an order-of-magnitude labor-spend sanity check, and it is arithmetic on an unsourced multiplicand: 54,300 reworked substance-use-disorder claims times $25.20 is about $1.4 million of annual rework labor, and the full behavioral-health figure is about $22 million, both inside one state's commercial segment. Read the shape, not the digits. Two things that shape tells us. First, a rework-automation product's addressable price per claim is bounded well below $25.20, because that figure is the provider's internal cost and the product has to beat it, not match it. Second, the economic character of the two products differs: automating rework on the 40.8% that already gets fixed sells cost takeout against a $25-ish internal line item, while preventing the non-recoverable denial sells recovered revenue. Recovered revenue is the easier sale, the larger per-unit value, and the one that survives a procurement conversation. That is a sharper product distinction than either brief had.
Verdict on the parent brief's relocation finding: supported, and from three directions it did not have. One, the Health Affairs resubmission structure itself is evidence the first submission was defective rather than the claim meritless, since payers reverse two-thirds of resubmissions. Two, "fewer than 1 percent of claims will get resubmitted conditional on a second denial" means the loop is one shot, so there is no downstream tail to build a durable product on. Three, and most directly, Change Healthcare's first-party data says 82% of denials are potentially avoidable, front-end causes are more than 41% of denials, and the single largest root cause, registration and eligibility at 22%, is frequently non-recoverable. Non-recoverable is the operative word: once the claim goes out with bad eligibility or a missing authorization, no amount of downstream parsing gets the money back. That is the healthcare analogue of the Cone of Accounting Bullshit in [[2026-09-17-cfo-secrets-double-entry-bookkeeping-ramp]], and it makes the convergence concrete rather than rhetorical. Shrink the gap between the clinical encounter plus its authorization and the first claim submission; do not build a better reconstructor. The honest qualification is that the Health Affairs authors explicitly could not separate clerical from clinical denials, so the strongest version of the upstream claim rests on Virginia's cause table and Change Healthcare's avoidability split, not on the 40.8% itself. The 40.8% sizes the labor. It does not prove where the leak is.
What this does to the family venture's shape. The rework market is real, roughly 440 times the appeals market in volume on Virginia's substance-use-disorder rows, and it is the right market to be in. But the pricing unit should be the prevented denial, not the processed denial, and the wedge should sit at authorization capture and first-pass claim construction for substance use disorder specifically, where Virginia's preauthorization gap runs about 6.6x medical/surgical. The honest risk to name to Michael and Christian is that this entire estimate borrows its central percentage from Medicare Advantage because the behavioral-health version does not exist until plan year 2027 data publishes.
Why this is in the vault
This closes open follow-up #4 of [[2026-10-04-behavioral-health-claim-denial-rate-primary-sources]] and is the sizing input for the family RCM/EOB AI venture with Michael and Christian: it decides whether the product's pricing unit is the processed denial or the prevented denial, and it supplies the one published percentage (40.8%) plus the two dates (plan year 2027 CMS behavioral-health split, and the 2019 vintage of the only measurement) that any pitch built on rework volume has to disclose.
Open follow-ups
- Does the Health Affairs data set, or Inovalon's underlying claims, permit a behavioral-health cut of the 40.8% resubmit-and-paid share? The authors are reachable and the question is one email, not a research project (affiliations not verified in this pass).
- Has any MGMA or HFMA member-only benchmarking report ever published a rework-cost-per-claim figure with a stated sample size, denominator and activity year? The $25.20 is the industry's load-bearing number and no first-party methodology for it was located from outside the paywall.
- Does the superseded 2017 Change Healthcare Healthy Hospital Revenue Cycle Index actually contain the $118 formal-appeal cost, or is that figure a secondary-source artifact with no first-party origin at all? The 2022 successor index contains no cost figure whatsoever.
- Do any clearinghouse or practice-management vendors (Availity, Waystar, Office Ally, Optum) publish a first-pass acceptance rate or resubmission rate broken out by specialty, which would give a behavioral-health rework share from a non-payer angle?
- What share of registration-and-eligibility denials are non-recoverable specifically for substance-use-disorder claims? Change Healthcare's "frequently non-recoverable" is the strongest upstream argument in this brief and it is a hospital all-specialty qualitative claim, not a measured behavioral-health share.
- Does the parent brief's 16.2 million Virginia denial count represent initial determinations or final post-resubmission status? Everything in this brief's volume arithmetic hinges on that, and the Bureau of Insurance could be asked directly.
Related
- [[2026-10-04-behavioral-health-claim-denial-rate-primary-sources]]
- [[2026-09-17-cfo-secrets-double-entry-bookkeeping-ramp]]
- [[2026-10-01-national-rcm-eob-ai-behavioral-health-scan]]
- [[2026-10-03-behavioral-health-billing-ai-bundled-vs-standalone]]
- [[2026-10-05-behavioral-health-billing-firm-ehr-count]]
- [[hcls/problem-log]]
Sources
Vault
~/rdco-vault/06-reference/research/2026-10-04-behavioral-health-claim-denial-rate-primary-sources.md(parent brief: Virginia and KFF appeals figures, Virginia cause table, relocation finding)~/rdco-vault/06-reference/2026-09-17-cfo-secrets-double-entry-bookkeeping-ramp.md(capture-at-the-event thesis; flaggedsponsored: true, sponsor Ramp)~/rdco-vault/06-reference/research/2026-10-01-national-rcm-eob-ai-behavioral-health-scan.md~/rdco-vault/06-reference/research/2026-10-03-behavioral-health-billing-ai-bundled-vs-standalone.md~/rdco-vault/06-reference/research/2026-10-05-behavioral-health-billing-firm-ehr-count.md~/rdco-vault/01-projects/hcls/problem-log.md
Primary, peer-reviewed, full text read at source
- Vabson B, Hicks AL, Chernew ME. "Medicare Advantage Denies 17 Percent Of Initial Claims; Most Denials Are Reversed, But Provider Payouts Dip 7 Percent." Health Affairs 2025;44(6), published 2 June 2025. PMID 40456040. https://www.healthaffairs.org/doi/10.1377/hlthaff.2024.01485 (plain fetch returns HTTP 403; retrieved via Playwright. Abstract cross-checked against the Europe PMC record for DOI 10.1377/hlthaff.2024.01485.)
Primary, first-party industry publication, original PDF downloaded and searched
- Change Healthcare. The Change Healthcare 2022 Revenue Cycle Denials Index. Eden Prairie (MN): Change Healthcare; 2022. https://blr.postclickmarketing.com/Global/FileLib/HLM/2022-revenue-cycle-denials-index.pdf (vendor-published internal analysis, 441 million hospital claim remits, July 2021 to June 2022; no cost-per-claim figure present)
Secondary
- Emerson J. "17% of Medicare Advantage claims are denied; 57% are overturned: Study." Becker's Payer Issues, 10 June 2025. https://www.beckerspayer.com/payer/17-of-medicare-advantage-claims-are-denied-57-are-overturned-study/ (plain fetch 403; retrieved via Playwright. Carries the 57% dollar-share figure and never mentions resubmission.)
Cost-figure provenance trail, vendor-published
- Merits, "What One Denial Costs." https://meritsappeals.com/research/what-one-denial-costs (Merits sells appeal-letter generation, so it has a commercial interest in appeal economics. Used only for its attribution table: MGMA $25.20 published March 2021 with no stated data year; MGMA December 2018 citing a 2017 Change Healthcare index for $118 per formal appeal; Premier $43.84 for 2022 and $57.23 for 2023.)
- Premier, "Trend alert: private payers retain profits by refusing or delaying legitimate medical claims," March 2024. https://premierinc.com/newsroom/blog/trend-alert-private-payers-retain-profits-by-refusing-or-delaying-legitimate-medical-claims
Flagged paywalled, not retried
- MGMA and HFMA member-only benchmarking libraries (the likely home of any sampled rework-cost-per-claim survey).
Research budget used: QMD 2 of 5; WebSearch 3 of 3; WebFetch 3 of 3 (2 returned HTTP 403, 1 usable); 2 Playwright retrievals and 1 direct PDF download as documented 403 workarounds; 1 Europe PMC application programming interface call; 1 sub-agent for parent-brief extraction.